Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SLGL Stock Forecast 2026-2027
$78.08
Current Price
$246.45M
Market Cap
Buy 4
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to SLGL Price Targets
+265.0%
To High Target of $285.00
+135.7%
To Median Target of $184.00
+40.9%
To Low Target of $110.00
SLGL Price Momentum
+5.6%
1 Week Change
+11.0%
1 Month Change
+828.4%
1 Year Change
+85.3%
Year-to-Date Change
-20.3%
From 52W High of $97.97
+907.5%
From 52W Low of $7.75
📊 TOP ANALYST CALLS
Did SLGL Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Sol-Gel is one of their latest high-conviction picks.
Latest SLGL Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, SLGL has a bullish consensus with a median price target of $184.00 (ranging from $110.00 to $285.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $78.08, the median forecast implies a 135.7% upside. This outlook is supported by 4 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Uy Ear at Mizuho, projecting a 265.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SLGL Analyst Ratings
4
Buy
0
Hold
0
Sell
SLGL Price Target Range
Low
$110.00
Average
$184.00
High
$285.00
Current: $78.08
Latest SLGL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SLGL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 24, 2026 | Mizuho | Uy Ear | Outperform | Initiates | $285.00 |
| Jan 20, 2026 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Dec 22, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Oct 27, 2025 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 19, 2024 | Raymond James | Outperform | Downgrade | $N/A | |
| May 22, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| May 20, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Nov 13, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 14, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 11, 2023 | Raymond James | Strong Buy | Maintains | $N/A | |
| Jul 24, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jul 19, 2023 | Raymond James | Strong Buy | Maintains | $N/A | |
| Jun 5, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Apr 12, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Mar 14, 2023 | Raymond James | Strong Buy | Maintains | $N/A | |
| Feb 1, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 14, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Nov 11, 2022 | Raymond James | Strong Buy | Maintains | $N/A | |
| Oct 21, 2022 | Jefferies | Hold | Initiates | $N/A | |
| Aug 29, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A |
Sol-Gel Technologies Ltd. (SLGL) Competitors
The following stocks are similar to Sol-Gel based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
SLGL
Sol-Gel Technologies
mkt cap
241.74M
Sol-Gel Technologies Ltd. (SLGL) Financial Data
Sol-Gel Technologies Ltd. has a market capitalization of $246.45M with a P/E ratio of -35.0x. The company generates $18.47M in trailing twelve-month revenue with a -5.7% profit margin.
Revenue growth is -89.5% quarter-over-quarter, while maintaining an operating margin of -3,569.4% and return on equity of -2.9%.
Valuation Metrics
Market Cap
$246.45M
Enterprise Value
$189.65M
P/E Ratio
-35.0x
PEG Ratio
0.6x
Price/Sales
13.1x
Growth & Margins
Revenue Growth (YoY)
-89.5%
Gross Margin
N/A
Operating Margin
-3,569.4%
Net Margin
-5.7%
EPS Growth
-89.5%
Financial Health
Cash/Price Ratio
+20.7%
Current Ratio
8.8x
Debt/Equity
1.7x
ROE
-2.9%
ROA
-3.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Sol-Gel Technologies Ltd. (SLGL) Business Model
About Sol-Gel Technologies Ltd.
What They Do
Develops dermatological treatments with innovative delivery systems.
Business Model
Sol-Gel Technologies generates revenue by creating and commercializing topical dermatology products using its proprietary aerosol-based drug-delivery platform. Its focus on prevalent skin conditions like acne and rosacea allows the company to address significant market needs, while its commitment to research and development fosters collaboration and partnerships to enhance its product offerings.
Additional Information
Founded in 1997 and based in Israel, Sol-Gel Technologies leverages nanotechnology for improved drug efficacy and patient experience. The company is positioned to make a substantial impact in the pharmaceutical sector, particularly within dermatology therapeutics.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
28
CEO
Mr. Moshe Arkin
Country
Israel
IPO Year
2007
Website
www.sol-gel.comSol-Gel Technologies Ltd. (SLGL) Latest News & Analysis
Latest News
Quick Summary
Sol-Gel received a method-of-use patent for patidegib (SGT-610) valid until 2044 and raised $33.1 million in an oversubscribed offering. A Phase 3 trial is ongoing, with results expected in Q4 2026.
Why It Matters
Sol-Gel's patent allowance extends market exclusivity for SGT-610, enhancing its competitive position. The successful fundraising boosts financial stability, while ongoing trials and licensing agreements signal growth potential.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sol-Gel Technologies Ltd. (SLGL) reported a quarterly loss of $1.31 per share, exceeding the Zacks Consensus Estimate of a loss of $1.84.
Why It Matters
Sol-Gel's smaller-than-expected loss signals potential operational improvements, which may boost investor confidence and positively affect stock performance.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) priced an underwritten offering of 459,112 shares at $72.00 each, raising approximately $33.1 million in gross proceeds.
Why It Matters
The share offering raises significant capital for Sol-Gel Technologies, potentially funding growth initiatives and impacting stock valuation and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sol-Gel Technologies Ltd. (SLGL) reported a quarterly loss of $1.07 per share, which was significantly worse than the Zacks Consensus Estimate of $0.39.
Why It Matters
The significant loss versus expectations indicates potential operational issues, raising concerns about Sol-Gel's financial health and future profitability, which can impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC on March 19, 2026.
Why It Matters
Filing the annual report indicates Sol-Gel's compliance with SEC regulations, providing transparency. Financial performance details may impact stock valuation and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sol-Gel Technologies plans to seek high-frequency BCC approval for SGT-610, potentially doubling its market potential. It also gained Health Canada approval for EPSOLAY and partnered with Viatris for Australia and New Zealand.
Why It Matters
Sol-Gel's pursuit of additional indications for SGT-610 could significantly enhance its revenue potential, while recent approvals and agreements expand its market presence, positively impacting stock value.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SLGL Stock
What is Sol-Gel Technologies Ltd.'s (SLGL) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Sol-Gel Technologies Ltd. (SLGL) has a median price target of $184.00. The highest price target is $285.00 and the lowest is $110.00.
Is SLGL stock a good investment in 2027?
According to current analyst ratings, SLGL has 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $78.08. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SLGL stock?
Wall Street analysts predict SLGL stock could reach $184.00 in the next 12 months. This represents a 135.7% increase from the current price of $78.08. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Sol-Gel Technologies Ltd.'s business model?
Sol-Gel Technologies generates revenue by creating and commercializing topical dermatology products using its proprietary aerosol-based drug-delivery platform. Its focus on prevalent skin conditions like acne and rosacea allows the company to address significant market needs, while its commitment to research and development fosters collaboration and partnerships to enhance its product offerings.
What is the highest forecasted price for SLGL Sol-Gel Technologies Ltd.?
The highest price target for SLGL is $285.00 from Uy Ear at Mizuho, which represents a 265.0% increase from the current price of $78.08.
What is the lowest forecasted price for SLGL Sol-Gel Technologies Ltd.?
The lowest price target for SLGL is $110.00 from at , which represents a 40.9% increase from the current price of $78.08.
What is the overall SLGL consensus from analysts for Sol-Gel Technologies Ltd.?
The overall analyst consensus for SLGL is bullish. Out of 2 Wall Street analysts, 4 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $184.00.
How accurate are SLGL stock price projections?
Stock price projections, including those for Sol-Gel Technologies Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 3:14 AM UTC